Blood thinner and inflammation monitoring after heart procedures
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are scheduled for a planned heart or blood vessel procedure where heparin (a blood thinner) will be used
- Or you are currently on ECMO (a machine that helps your heart and lungs)
- You are not pregnant
- You are not taking part in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
This study measures how active white blood cells and inflammation are during complex heart surgery using a heart-lung machine. It may help doctors better understand what triggers inflammation during surgery and how to improve care.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This Phase 3 study tests whether aiming for a lower blood-thinning test result (INR) can reduce bleeding risk in people with a specific type of mechanical heart valve. The trial checks if this lower INR goal is safer while still protecting against dangerous clots.
Hear when a new Heart Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.